The Medical Advisor

The common denominator for overall health—including longevity, brain health, gut health, liver health, immune health, and kidney health—is mitochondrial health. Many chronic diseases can be traced to mitochondrial dysfunction. Seemingly diverse conditions—including  diabetes ,  hypertension ,  heart disease ,  cancer , allergies, autoimmune diseases such as rheumatoid arthritis, and even various mental illnesses—can be understood through a “unified theory” of mitochondrial imbalance. Mitochondria are involved in many vital processes in human cells, including energy production, fatty-acid oxidation, and the Tricarboxylic Acid (TCA) cycle, calcium signaling, apoptosis (cellular death), and heat production. However to simplify things let’s talk about energy and longevity which is what their function translates to for practical purposes. And to help this occur, we can review the health practices, along with the best supplements to improve mitocho...

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for type 2 diabetes, have rapidly expanded into obesity management and are now being explored across multiple therapeutic domains. Recent studies (2024–2026) suggest potential benefits in dermatologic diseases, neuroinflammatory conditions, metabolic dysfunction, and systemic inflammation. In parallel, emerging clinical guidance highlights the importance of nutritional status, targeted supplementation, and safety considerations—including concerns around compounded formulations. This review synthesizes current evidence and practical considerations for optimizing outcomes. 1. Introduction GLP-1 receptor agonists—including semaglutide, liraglutide, and tirzepatide—have transformed the management of obesity and type 2 diabetes. Their mechanisms extend beyond glucose regulation to include: Appetite suppression Delayed gastric emptying Anti-inflammatory effects Modulation of insulin sensitivity As clinical us...